LI-RADS ancillary features favoring benignity: is there a role in LR-5 observations?

被引:2
|
作者
Cannella, Roberto [1 ,2 ]
Vernuccio, Federica [1 ]
Antonucci, Michela [1 ]
Gagliano, Domenico Salvatore [1 ]
Matteini, Francesco [1 ]
Midiri, Massimo [1 ]
Brancatelli, Giuseppe [1 ]
机构
[1] Univ Hosp Paolo Giaccone, Sect Radiol, Dept Biomed Neurosci & Adv Diagnost, BiND, Via Vespro 129, I-90127 Palermo, Italy
[2] Univ Palermo, Dept Hlth Promot Sci Maternal & Infant Care, PROMISE, Internal Med & Med Specialties, I-90127 Palermo, Italy
关键词
Liver; Cirrhosis; Hepatocellular carcinoma; Magnetic resonance imaging; Gadoxetate disodium; CLINICAL-PRACTICE GUIDELINES; DATA SYSTEM V2014; HEPATOCELLULAR-CARCINOMA; SIGNAL INTENSITY; MRI; MANAGEMENT; DIAGNOSIS; CT;
D O I
10.1007/s00330-021-08267-0
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives The Liver Imaging Reporting and Data System algorithm allows category downgrade in the presence of ancillary features (AFs) favoring benignity, even in observations categorized as LR-5. This study aims to assess the role of AFs favoring benignity in LR-5 observations and their impact on category downgrade. Methods This study included high-risk patients with at least one LR-5 observation imaged with gadoxetate disodium MRI. Three readers with different experience levels independently evaluated the presence of AFs favoring malignancy (not hepatocellular carcinoma (HCC) in particular and HCC in particular) and AFs favoring benignity. Category downgrade was considered possible in the presence of >= 1 AF favoring benignity and no AF favoring malignancy. Correlation between observations size and number of AFs was assessed using Spearman's rank correlation coefficient. Cohen's kappa (k) test was used to assess inter-reader agreement. Results The final study cohort included 162 LR-5 (mean size: 23 +/- 16 mm) in 119 patients. AFs favoring benignity were reported in 9 (5.6%), 20 (12.3%), and 10 (6.2%) LR-5 observations by reader 1, reader 2, and reader 3, respectively. Hepatobiliary phase isointensity was observed in 6 (3.7%), 2 (1.2%), and 7 (4.3%) observations, respectively. Category downgrade was considered possible in only one (0.6%) observation by reader 1 and reader 3. There was a significant correlation between observation size and number of AFs favoring malignancy (p < 0.001), not HCC in particular (p <= 0.010), and favoring HCC in particular (p < 0.001). Inter-reader agreement of AFs favoring benignity was poor to moderate (k range: - 0.01, 0.43). Conclusions AFs favoring benignity are not uncommon in LR-5 observations, but category downgrade is exceptional.
引用
收藏
页码:1804 / 1812
页数:9
相关论文
共 50 条
  • [41] Role of Contrast-Enhanced Ultrasonography in Hepatocellular Carcinoma by Using LI-RADS and Ancillary Features: A Single Tertiary Centre Experience
    Ciocalteu, Adriana
    Iordache, Sevastita
    Cazacu, Sergiu Marian
    Urhut, Cristiana Marinela
    Sandulescu, Sarmis Marian
    Ciurea, Ana-Maria
    Saftoiu, Adrian
    Sandulescu, Larisa Daniela
    DIAGNOSTICS, 2021, 11 (12)
  • [42] LI-RADS Nonradiation Treatment Response Algorithm Version 2024: Diagnostic Performance and Impact of Ancillary Features
    Zhou, Shuwei
    Zhou, Guofeng
    Shen, Yang
    Xia, Tianyi
    Zhao, Ben
    Sun, Ziying
    Gao, Lei
    Li, Binrong
    Wang, Weilang
    Zhang, Shuhang
    Opara, Noble C.
    Chen, Xunjun
    Ju, Shenghong
    Wang, Yuan-Cheng
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2025, 224 (02)
  • [43] Diagnostic performance of LR-5 based on hypointensity on Gd-EOB-DTPAeenhanced MRI in the hepatobiliary phase for sHCC using LI-RADS v2018 criteria
    Lin, B.
    Zhang, W.
    Jiang, Y.
    Qin, Y.
    Mishra, P. K.
    Chen, J. Y.
    Zeng, Y. D.
    Zhou, Z. P.
    CLINICAL RADIOLOGY, 2025, 81
  • [44] Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors
    Yi Wang
    Gui-Qi Zhu
    Chang-Wu Zhou
    Na Li
    Chun Yang
    Meng-Su Zeng
    European Radiology, 2022, 32 : 5166 - 5178
  • [45] Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors
    Wang, Yi
    Zhu, Gui-Qi
    Zhou, Chang-Wu
    Li, Na
    Yang, Chun
    Zeng, Meng-Su
    EUROPEAN RADIOLOGY, 2022, 32 (08) : 5166 - 5178
  • [46] Clinicoradiographic predictors of progression of an intermediate hepatic lesion (LI-RADS 3) to hepatocellular carcinoma (LI-RADS 5)
    Hannan, Lindsay M.
    Ojeda, Patricia I.
    Mieloszyk, Rebecca J.
    Harris, William P.
    Park, James O.
    Bhargava, Puneet
    HEPATOMA RESEARCH, 2021, 7 : 7 - 78
  • [47] Correlation of LI-RADS LR3 or LR4 Observations with Histopathologic Diagnosis of Hepatocellular Carcinoma in Liver Transplant Patients
    Lin, Bo
    Dunn, Colin
    Browning, Travis
    Rich, Nicole
    Vagefi, Parsia
    Yokoo, Takeshi
    Zhu, Hao
    Singal, Amit
    Gopal, Purva
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1132 - 1133
  • [48] Should LR-M and LR-TIV Remain Separate Categories in LI-RADS?
    Kim, Myeong-Jin
    Lee, Sunyoung
    HEPATOLOGY, 2019, 69 (04) : 1842 - 1842
  • [49] Correlation of LI-RADS LR3 or LR4 Observations with Histopathologic Diagnosis of Hepatocellular Carcinoma in Liver Transplant Patients
    Lin, Bo
    Dunn, Colin
    Browning, Travis
    Rich, Nicole
    Vagefi, Parsia
    Yokoo, Takeshi
    Zhu, Hao
    Singal, Amit
    Gopal, Purva
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1132 - 1133
  • [50] LR- M Observations on Contrast-Enhanced Ultrasound: Detection of Hepatocellular Carcinoma Using Additional Features in Comparison With Current LI-RADS Criteria
    Huang, Yang
    Xian, Meng-Fei
    Xie, Wen-Xuan
    Pan, Kang-Ming
    Zeng, Dan
    Huang, Hui
    Li, Ming-De
    Xie, Xiao-Yan
    Kuang, Ming
    Lu, Ming-De
    Chen, Li-Da
    Wang, Wei
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2022, 219 (01) : 76 - 85